饮食对多发性硬化症疲劳和生活质量疗效的系统综述与随机试验网络Meta分析
该研究通过系统综述和网络Meta分析评估不同饮食方案对多发性硬化症相关疲劳和生活质量的影响,纳入12项随机试验共608名参与者,比较8种饮食干预。古人类饮食、低脂饮食和地中海饮食在改善疲劳方面优于常规饮食,古人类饮食和地中海饮食在改善躯体和精神生活质量方面也优于常规饮食,但证据可信度极低,需高质量随机对照试验证实。
要点
- 古人类饮食、低脂饮食和地中海饮食可减轻多发性硬化症相关疲劳。
- 古人类饮食和地中海饮食可改善躯体和精神生活质量。
- 所有直接比较的证据可信度极低,需高质量随机对照试验证实。
核心结论
- 若干饮食干预可能减轻多发性硬化症相关疲劳并改善躯体和精神生活质量,但由于本网络Meta分析的局限性(源于纳入试验质量低),这些发现必须在高品质随机对照试验中证实。
研究设计与样本
- 系统综述与网络Meta分析,纳入12项随机试验,比较8种饮食干预(低脂、地中海、生酮、抗炎、古人类、禁食、热量限制和对照[常规饮食]),共608名参与者。
主要发现
- 与对照相比,古人类饮食(SMD -1.27;95% CI -1.81至-0.74)、低脂饮食(SMD -0.90;95% CI -1.39至-0.42)和地中海饮食(SMD -0.89;95% CI -1.15至-0.64)可更大程度减轻疲劳。
- 与对照相比,古人类饮食(SMD 1.01;95% CI 0.40-1.63)和地中海饮食(SMD 0.47;95% CI 0.08-0.86)可更大程度改善躯体生活质量。
- 与对照相比,古人类饮食(SMD 0.81;95% CI 0.26-1.37)和地中海饮食(SMD 0.36;95% CI 0.06-0.65)在改善精神生活质量方面更有效。
- 所有直接比较的NutriGRADE证据可信度极低,原因是大多数纳入试验存在高或中等偏倚风险、样本量小以及本网络Meta分析纳入研究数量有限。
关键数值与推荐
- 纳入标准:随机试验且含饮食干预;基于McDonald标准的成年明确多发性硬化症患者;患者报告的疲劳和/或生活质量结局;最低干预周期4周。
- 疲劳改善:古人类饮食SMD -1.27(95% CI -1.81至-0.74),低脂饮食SMD -0.90(95% CI -1.39至-0.42),地中海饮食SMD -0.89(95% CI -1.15至-0.64),均优于对照。
- 躯体生活质量改善:古人类饮食SMD 1.01(95% CI 0.40-1.63),地中海饮食SMD 0.47(95% CI 0.08-0.86),均优于对照。
- 精神生活质量改善:古人类饮食SMD 0.81(95% CI 0.26-1.37),地中海饮食SMD 0.36(95% CI 0.06-0.65),均优于对照。
临床怎么用
- 原文未据此给出推荐。
局限性
- 大多数纳入试验存在高或中等偏倚风险。
- 纳入试验样本量小。
- 本网络Meta分析纳入的研究数量有限。
- 所有直接比较的NutriGRADE证据可信度极低。
- 这些发现必须在高品质随机对照试验中证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Emerging evidence suggests a role for diet in multiple sclerosis (MS) care; however, owing to methodological issues and heterogeneity of dietary interventions in preliminary trials, the current state of evidence does not support dietary recommendations for MS. The objective of this study was to assess the efficacy of different dietary approaches on MS-related fatigue and quality of life (QoL) through a systematic review of the literature and network meta-analysis (NMA). METHODS: Electronic database searches were performed in May 2021. Inclusion criteria were (1) randomized trial with a dietary intervention, (2) adults with definitive MS based on McDonald criteria, (3) patient-reported outcomes for fatigue and/or QoL, and (4) minimum intervention period of 4 weeks. For each outcome, standardized mean differences (SMDs) were calculated and included in random effects NMA to determine the pooled effect of each dietary intervention relative to each of the other dietary interventions. The protocol was registered at PROSPERO (CRD42021262648). RESULTS: Twelve trials comparing 8 dietary interventions (low-fat, Mediterranean, ketogenic, anti-inflammatory, Paleolithic, fasting, calorie restriction, and control [usual diet]), enrolling 608 participants, were included in the primary analysis. The Paleolithic (SMD -1.27; 95% CI -1.81 to -0.74), low-fat (SMD -0.90; 95% CI -1.39 to -0.42), and Mediterranean (SMD -0.89; 95% CI -1.15 to -0.64) diets showed greater reductions in fatigue compared with control. The Paleolithic (SMD 1.01; 95% CI 0.40-1.63) and Mediterranean (SMD 0.47; 95% CI 0.08-0.86) diets showed greater improvements in physical QoL compared with control. For improving mental QoL, the Paleolithic (SMD 0.81; 95% CI 0.26-1.37) and Mediterranean (SMD 0.36; 95% CI 0.06-0.65) diets were more effective compared with control. However, the NutriGRADE credibility of evidence for all direct comparisons is very low because of most of the included trials having high or moderate risk of bias, small sample sizes, and the limited number of studies included in this NMA. DISCUSSION: Several dietary interventions may reduce MS-related fatigue and improve physical and mental QoL; however, because of the limitations of this NMA, which are driven by the low quality of the included trials, these findings must be confirmed in high-quality, randomized, controlled trials.
引用
- Snetselaar LG, Cheek JJ, Fox SS, et al. Efficacy of Diet on Fatigue and Quality of Life in Multiple Sclerosis: A Systematic Review and Network Meta-analysis of Randomized Trials. Neurology. 2022. PMID: 36257717. doi:10.1212/WNL.0000000000201371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。